{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"0","value":"0"},{"groupId":"OG001","lowerLimit":"28.1","upperLimit":"60.7","value":"41.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"104"},{"groupId":"OG001","value":"39"}],"units":"Participants"}],"title":"Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"232.8","upperLimit":"371.8","value":"294.2"},{"groupId":"OG001","lowerLimit":"351.9","upperLimit":"660.7","value":"482.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"94"},{"groupId":"OG001","value":"33"}],"units":"Participants"}],"title":"Month 7"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"48.7","upperLimit":"81.6","value":"63.1"},{"groupId":"OG001","lowerLimit":"141.0","upperLimit":"326.6","value":"214.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"88"},{"groupId":"OG001","value":"30"}],"units":"Participants"}],"title":"Month 12"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"29.7","upperLimit":"51.7","value":"39.2"},{"groupId":"OG001","lowerLimit":"158.0","upperLimit":"377.5","value":"244.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"29"}],"units":"Participants"}],"title":"Month 18"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"28.7","upperLimit":"52.8","value":"39.0"},{"groupId":"OG001","lowerLimit":"103.3","upperLimit":"253.7","value":"161.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"73"},{"groupId":"OG001","value":"31"}],"units":"Participants"}],"title":"Month 24"}],"denoms":[{"counts":[{"groupId":"OG000","value":"104"},{"groupId":"OG001","value":"39"}],"units":"Participants"}],"description":"Geometric mean concentration of antibodies for HPV 18 at each visit","dispersionType":"95% Confidence Interval","groups":[{"description":"Sero-negative for HPV 18 at baseline.","id":"OG000","title":"HPV 18 Sero-negative at Baseline"},{"description":"Sero-positive for HPV 18 at baseline","id":"OG001","title":"HPV 18 Sero-positive at Baseline"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"Eligible participants who received at least one vaccination with evaluable serum assessments.","reportingStatus":"POSTED","timeFrame":"Baseline through 24 months","title":"Geometric Mean Titers for HPV 18","type":"SECONDARY","unitOfMeasure":"mMU/mL"}